alexa Mitochondrial Dynamics and Cardiac Function in Metabolic Disorders | Open Access Journals
ISSN: 2167-0943
Journal of Metabolic Syndrome
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Mitochondrial Dynamics and Cardiac Function in Metabolic Disorders

Julieta Díaz-Juárez1 and Jorge Suarez2*

1Department of Pharmacology, Instituto Nacional de Cardiología Ignacio Chávez, Ciudad de México, México

2Department of Medicine, University of California, San Diego, USA

*Corresponding Author:
Jorge Suarez
Department of Medicine, University of California
San Diego, USA
Tel: (858) 534-9931
Fax: (858) 534-9932
E-mail: [email protected]

Received date: May 02, 2017; Accepted date: May 03, 2017; Published date: May 10, 2017

Citation: Díaz-Juárez J, Suarez J (2017) Mitochondrial Dynamics and Cardiac Function in Metabolic Disorders. J Metabolic Synd 6:e121. doi: 10.4172/ 2167-0943.1000e121

Copyright: © 2017 Díaz-Juárez J, et al. This is an open-access article distributed under the terms of the creative commons attribution license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Metabolic Syndrome


Metabolic syndrome (MetS) is the name of a group of risk factors that can lead to develop several diseases including diabetes mellitus (DM). MetS is accompanied by central obesity, dyslipidemia, compromised fasting glucose, and hypertension [1]. DM, especially type 2 diabetes (DM2), is a growing health care problem resulting in significant cardiovascular disease. Diabetic heart disease includes decreased cardiac contractile function in the absence of ischemia, termed diabetic cardiomyopathy (DCM). Most diabetic patients die of cardio-vascular disease. Cardiac Myocytes (CM) from diabetic type 1 (DM1) and (DM2) hearts exhibit abnormal cytosolic and sarcoplasmic reticulum (SR) calcium (Ca) handling, disturbed metabolic fuel flux, decreased mitochondrial (Mito) energetic efficiency and increased reactive oxygen species (ROS) production. Mitochondrial structural and dynamic abnormalities are also associated to DM. Dysfunctional Mito in DM2 may be due to impaired Mito dynamics, however, whether Mito dynamics contribute to MetS or DCM or are a therapeutic target for this disease have been only incompletely investigated. Recent work has highlighted the importance of mitochondrial morphological dynamics in cells and animal physiology. Because mitochondria constantly fuse and divide, an imbalance of these two processes dramatically alters overall mitochondrial morphology [2], and it is now clear that mitochondrial dynamics play important roles in mitochondrial function, including development, apoptosis, and functional complementation of mitochondrial DNA mutations by content mixing [3-9]. Fused networks of connected mitochondria may also facilitate the transmission of Ca2+ signals and membrane potential within cells [10,11]. Mito change their morphology between elongated, interconnected Mito networks (fusion) and a fragmented disconnected arrangement (fission). Dynamin proteins regulate Mito fusion (Mitofusins 1 and 2 (MFN1/2) [12], and optic atrophy1 (OPA1)) and fission (Dynamin-related protein 1 (DRP1) and mitochondrial fission protein1 (FIS1)) [3,13], and have been implicated in biological processes including metabolism, apoptosis, and autophagy, although the majority of studies have been confined to non-cardiac cells [14-22]. Changes in mitochondrial morphology are relevant to various aspects of cardiovascular biology and pathology. These include cardiac development, the response to ischemia-reperfusion injury, heart failure, diabetes mellitus, and apoptosis [14,16,18,20,23]. Furthermore, mitochondrial dynamics are important to maintain the mitochondrial membrane potential (ΔΨm) which in turn, is vital for mitochondrial calcium import and ATP production. In addition, we have highlighted the importance of normal mitochondrial calcium handling in MetS [24]. It has been suggested that FIS1 recruits DRP1 from the cytosol to mitochondria for the fission reaction [25,26]. We have demonstrated that glucose concentrations that mimic hyperglycemia in humans increase mitochondrial fission in cardiac muscle cells [27]. Increased Mito fission has been found in hearts of diabetic patients [28]. We can postulate that DM-induced abnormalities of mitochondrial fission/ fusion dynamics can be reverted to towards normal despite persistent DM. We think that this can be achieved by the inhibition of specific fission-related proteins or activating fusion by overexpressing fusionrelated proteins in cardiac myocytes. We postulate that these specific rescue effects may lead to improved cardiac function and survival in DM. Tools to inhibit Mito fission have only been available recently. Three molecules have been studied in the last 5 years: Mdivi [29], P110 [30], and Dyanosore [31]. Work has been performed in human disease animal models to test the beneficial effects of these compounds [32-35]. Mdivi is the most tested among these compounds. Mdivi interfere with the correct assemble of the GTPase domain of DRP1 inhibiting its enzymatic activity [29]. Inhibiting Mito fission with Mdivi protects against cell death of hippocampal neurons in pilocarpine-induced seizures in rats [32,34]. Furthermore, Mdiviinhibition of excessive Mito fission after myocardial infarction prevents long-term cardiac dysfunction in mice [36], ischemia/reperfusion damage [37] and improves function in pressure overload-induced heart failure [38]. In addition, Mdivi treatment protected against myocardial ischemia/reperfusion injury in diabetic mice. Unfortunately, beneficial effects of Mdivi treatment in MetS or diabetic cardiomyopathy have not been investigated. MetS leads to set the stage for serious problems. MetS double a patient risk of blood vessel and heart disease, which can lead to heart attacks and strokes. They increase to develop risk to develop diabetes by five times. Therefore, new and more effective therapeutics to prevent MetS complications must be developed. Inhibition of mitochondrial fission seems to be a promising therapeutic target that requires further investigation.


This Manuscript was supported by Grant from UC-MEXUS CONACYT (CN 15-1489).


Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Recommended Conferences

Article Usage

  • Total views: 255
  • [From(publication date):
    May-2017 - Sep 26, 2017]
  • Breakdown by view type
  • HTML page views : 220
  • PDF downloads :35

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals


[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version